Literature DB >> 23066416

Clinical characteristics and risk factors for peripartum cardiomyopathy.

G Y Huang1, L Y Zhang, M A Long-Le, Le-Xin Wang.   

Abstract

BACKGROUND: Peripartum cardiomyopathy (PPCM) is a potentially fatal form of heart failure and the recognition of its risk factors is important for prevention and treatment.
OBJECTIVE: To explore the clinical characteristics and the risk factors for PPCM.
METHODS: Echocardiographic was used to examine the left ventricular ejection fraction (LVEF). Blood level of troponin I (cTNI), high sensitive C-reaction protein (hs-CRP), NT-proBNP was measured. All PPCM occurred within weeks following delivery.
RESULTS: Fifty-two PPCM patients and 52 normal delivery subjects (control group) were included in this study. Compared with the control group, PPCM patients were older, with a higher level of blood pressure, and a higher rate of suspected respiratory infection. The level of leucocytes, hs-CRP, cTNI and NT-proBNP in PPCM patients were higher than in the control. Multivariate logistic regression analysis showed that elevated plasma hs-CRP (OR =1.86, p<0.05), respiratory infection (OR = 2.87, p<0.01), and hypertension (OR =1.68, p < 0.05) were independent risk factors for PPCM. During the follow up of 21.6±5.4 d, one patient (1.9%) died probably of heart failure but other patients remained well.
CONCLUSION: Hypertension, respiratory infection, and elevated plasma hs-CRP seem to be associated with the pathogenesis of peripartum cardiomyopathy in this patient population.

Entities:  

Keywords:  C-reaction protein; hypertension; inflammation; mortality; peripartum cardiomyopathy

Mesh:

Substances:

Year:  2012        PMID: 23066416      PMCID: PMC3462514     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  15 in total

1.  African-American women have a higher risk for developing peripartum cardiomyopathy.

Authors:  Mindy B Gentry; James K Dias; Antonio Luis; Rakesh Patel; John Thornton; Guy L Reed
Journal:  J Am Coll Cardiol       Date:  2010-02-16       Impact factor: 24.094

Review 2.  Peripartum cardiomyopathy: a comprehensive review.

Authors:  John Abboud; Yahya Murad; Carol Chen-Scarabelli; Louis Saravolatz; Tiziano M Scarabelli
Journal:  Int J Cardiol       Date:  2007-01-17       Impact factor: 4.164

3.  Incidence, mortality, and racial differences in peripartum cardiomyopathy.

Authors:  Somjot S Brar; Steven S Khan; Gagandeep K Sandhu; Michael B Jorgensen; Neil Parikh; Jin-Wen Y Hsu; Albert Yuh-Jer Shen
Journal:  Am J Cardiol       Date:  2007-06-06       Impact factor: 2.778

4.  Poor outcome of indigent patients with peripartum cardiomyopathy in the United States.

Authors:  Kalgi A Modi; Sandra Illum; Karim Jariatul; Gloria Caldito; Pratap C Reddy
Journal:  Am J Obstet Gynecol       Date:  2009-06-28       Impact factor: 8.661

5.  Understanding peripartum cardiomyopathy, 2008.

Authors:  James D Fett
Journal:  Int J Cardiol       Date:  2008-06-30       Impact factor: 4.164

6.  Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution.

Authors:  James D Fett; Len G Christie; Robert D Carraway; Joseph G Murphy
Journal:  Mayo Clin Proc       Date:  2005-12       Impact factor: 7.616

7.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

8.  Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1.

Authors:  K Sliwa; D Skudicky; A Bergemann; G Candy; A Puren; P Sareli
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

9.  Inflammatory markers and cytokines in peripartum cardiomyopathy: a delicate balance.

Authors:  James D Fett; Aftab A Ansari
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

10.  A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

Authors:  Denise Hilfiker-Kleiner; Karol Kaminski; Edith Podewski; Tomasz Bonda; Arnd Schaefer; Karen Sliwa; Olaf Forster; Anja Quint; Ulf Landmesser; Carola Doerries; Maren Luchtefeld; Valeria Poli; Michael D Schneider; Jean-Luc Balligand; Fanny Desjardins; Aftab Ansari; Ingrid Struman; Ngoc Q N Nguyen; Nils H Zschemisch; Gunnar Klein; Gerd Heusch; Rainer Schulz; Andres Hilfiker; Helmut Drexler
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

View more
  11 in total

1.  Back to our roots: infections, HIV and maternal mortality in Africa.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2012-03       Impact factor: 0.927

Review 2.  The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis.

Authors:  Natalie Bello; Iliana S Hurtado Rendon; Zoltan Arany
Journal:  J Am Coll Cardiol       Date:  2013-09-04       Impact factor: 24.094

Review 3.  Pathophysiology and risk factors of peripartum cardiomyopathy.

Authors:  Martijn F Hoes; Zoltan Arany; Johann Bauersachs; Denise Hilfiker-Kleiner; Mark C Petrie; Karen Sliwa; Peter van der Meer
Journal:  Nat Rev Cardiol       Date:  2022-01-11       Impact factor: 49.421

Review 4.  Peripartum cardiomyopathy: A puzzle closer to solution.

Authors:  James D Fett
Journal:  World J Cardiol       Date:  2014-03-26

Review 5.  Peripartum Cardiomyopathy: an Update.

Authors:  Feriel Azibani; Karen Sliwa
Journal:  Curr Heart Fail Rep       Date:  2018-10

6.  Morphofunctional cardiac changes in pregnant women: associations with biomarkers.

Authors:  Takeshi Umazume; Takahiro Yamada; Satoshi Yamada; Satoshi Ishikawa; Itsuko Furuta; Hiroyuki Iwano; Daisuke Murai; Taichi Hayashi; Kazunori Okada; Mamoru Morikawa; Takashi Yamada; Kota Ono; Hiroyuki Tsutsui; Hisanori Minakami
Journal:  Open Heart       Date:  2018-07-16

7.  Prospective study on changes in blood variables in pregnant women at higher risk of peripartum cardiomyopathy.

Authors:  Takeshi Umazume; Takahiro Yamada; Satoshi Ishikawa; Takashi Yamada; Takahiro Koyama; Itsuko Furuta; Mamoru Morikawa; Satoshi Yamada; Hisanori Minakami
Journal:  ESC Heart Fail       Date:  2015-07-28

8.  Systematic review and meta-analysis of prolactin and iron deficiency in peripartum cardiomyopathy.

Authors:  Sinaida Cherubin; Taylar Peoples; Jessica Gillard; Samira Lakhal-Littleton; Jennifer J Kurinczuk; Manisha Nair
Journal:  Open Heart       Date:  2020-10

Review 9.  Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance.

Authors:  Marco Francone
Journal:  ISRN Radiol       Date:  2014-02-04

10.  Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping.

Authors:  Yao-Dan Liang; Yuan-Wei Xu; Wei-Hao Li; Ke Wan; Jia-Yu Sun; Jia-Yi Lin; Qing Zhang; Xiao-Yue Zhou; Yu-Cheng Chen
Journal:  J Cardiovasc Magn Reson       Date:  2020-01-06       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.